Ongoing research refines understanding of GLP-1 drugs Emerging research is deepening the medical communitys understanding of GLP-1 drugs, revealing potential benefits, health effects, and interactions with other compounds
Ro Offers Eli Lilly's Foundayo, the Newest GLP-1 Innovation Foundayo gives patients a new once daily pill option and expands Ros comprehensive weight loss formulary April 9, 2026 Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Companys newest oral GLP-1 innovation on the Ro platform, adding to Ros already comprehensive formulary of FDA-approved GLP-1s
Nevertheless, faeces in general tend to be a rich source of B12 that we certainly do not recommend but its a source of B12 for many animals and may explain why in predominantly vegetarian populations in areas lacking sanitation, poor people tend to have a better B12 status than the urban middle class (Sobczyska-Malefora et al., 2021)
Who it helps: This primarily benefits people with high-deductible plans or those paying coinsurance based on the sticker price.
